6568 — KNC Laboratories Co Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMicro CapContrarian

Annual income statement for KNC Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,348	6,029	7,441	8,628	9,155
Cost of Revenue
Gross Profit	1,730	1,760	2,107	3,304	3,296
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,793	5,485	6,530	6,491	7,076
Operating Profit	555	544	911	2,137	2,079
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	705	586	917	2,172	2,093
Provision for Income Taxes
Net Income After Taxes	518	400	643	1,543	1,493
Net Income Before Extraordinary Items
Net Income	518	400	643	1,543	1,493
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	518	400	643	1,543	1,493
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	61.3	59.6	99.6	203	194
Dividends per Share